U.S. market Closed. Opens in 1 day 15 hours 28 minutes

PCVX | Vaxcyte, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue75.00M9.20M1.80M1.41M1.23MN/A
Gross Profit-75.00M-9.20M-1.80M-1.41M-1.23MN/A
Operating Expenses393.04M207.33M102.08M87.10M53.92M35.53M
Selling, General & Admin60.70M39.81M25.26M16.02M8.55M5.39M
Research & Development332.34M169.45M78.41M73.56M45.61M30.14M
Other Operating Expenses75.00M-1.93M-1.58M-2.48M-237.00K5.18M
Operating Income-468.04M-232.26M-103.67M-89.58M-54.15M-35.53M
Other Expenses / Income65.78M8.77M3.59M364.00K3.88M5.22M
Before Tax Income-402.27M-223.49M-100.08M-89.22M-50.27M-29.48M
Income Tax ExpensesN/A16.16M7.00K-1.40M3.23M6.12M
Net Income-402.27M-239.64M-100.08M-87.82M-53.50M-29.48M
Interest ExpensesN/A2.00K7.00K7.00K40.00K75.00K
Basic Shares Outstanding97.16M64.88M51.92M51.07M48.86M25.60M
Diluted Shares Outstanding97.16M64.88M51.92M51.07M48.86M25.60M
EBITDA-464.88M-189.78M-98.28M-86.86M-48.87M-28.41M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-402.27M-223.48M-100.07M-89.21M-50.23M-23.29M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙